Inici › Malaltia de Crohn › Florida › Orlando
Assaigs clínics de Malaltia de Crohn a Orlando, FL
17 estudis de Malaltia de Crohn busquen participants en centres de Orlando i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
ReclutantFase 3
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ReclutantFase 2
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · a 16 mi
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
ReclutantFase 4
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · a 16 mi
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
ReclutantFase 2
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · a 24 mi
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 2
- AdventHealth (Florida Hospital) Medical Group, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ReclutantFase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · a 16 mi
- i 1 més
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · a 16 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
ReclutantFase 2
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · a 16 mi
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
ReclutantFase 4
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · a 16 mi
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Reclutant
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
ReclutantEstudi observacional
- AdventHealth, Orlando
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
ReclutantFase 4
- Digestive & Liver Center of Florida, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
ReclutantFase 2
- Orlando Health, Inc., Orlando
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
ReclutantFase 2
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · a 16 mi
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
ReclutantFase 2
- Mirador Therapeutics Selected Site, Orlando
Assaigs de Malaltia de Crohn en altres ciutats
- New York City, NY35 estudis
- Cleveland, OH19 estudis
- St. Louis, MO19 estudis
- Boston, MA19 estudis
- Miami, FL19 estudis
- Houston, TX17 estudis
- Atlanta, GA17 estudis
- Tyler, TX16 estudis
- San Diego, CA15 estudis
- San Antonio, TX15 estudis
- Los Angeles, CA15 estudis
- Philadelphia, PA13 estudis
Altres estudis a Orlando
- Càncer de pulmó de cèl·lules no petites44 estudis
- Obesitat31 estudis
- Càncer metastàtic29 estudis
- Sobrepès27 estudis
- Malaltia d'Alzheimer25 estudis
- Diabetis tipus 224 estudis
- Càncer (tots els tipus)24 estudis
- Càncer de mama23 estudis
- Càncer d'ovari22 estudis
- Colitis ulcerosa22 estudis
- Càncer de pulmó21 estudis
- Càncer colorrectal19 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.